SV Latam Capital — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Encellinencellin.comin𝕏Jun 2019SEC filingmedium confidence
Encellin develops next-generation therapies for patients with chronic unmet clinical needs, using technology originating from Dr.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Tejal Desai(Technology Expert, Founder)Ronald Martell(Strategic Advisor, Founder)Crystal Nyitray(Executive Officer, Director, Promoter)Grace Wei(Executive Officer, Director, Promoter)Maria del Consuelo Valverde(Director)
Board seatMaria del Consuelo Valverde· per SEC Form D · $2.7M raise · filed Jul 2019
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.